Please login to the form below

Not currently logged in
Email:
Password:

Ben Venue

This page shows the latest Ben Venue news and features for those working in and with pharma, biotech and healthcare.

Pfizer inks $360m deal to buy InnoPharma

Pfizer inks $360m deal to buy InnoPharma

because of manufacturing quality issues that have interrupted supplies from companies such as Hospira and Boehringer Ingelheim's Ben Venue unit.

Latest news

  • Boehringer sells injectables business to Hikma for $300m Boehringer sells injectables business to Hikma for $300m

    Bedford Laboratories is part of troubled Ben Venue division. Boehringer Ingelheim has sold troubled sterile injectables subsidiary Bedford Laboratories to Hikma Pharmaceuticals in a deal valued at $300m. ... Local officials in Ohio said they were

  • EMA publishes European drug shortage details EMA publishes European drug shortage details

    The plan is built on lessons learned during recent drug shortages, such as those caused by manufacturing problems at the Ben Venue  manufacturing plant in the US, and aims to provide

  • FDA creates drug shortage plan FDA creates drug shortage plan

    The plan also acknowledges that poor manufacturing standards, such of those at Ben Venue, is one of the main reasons for drug shortages, and highlights opportunities for companies to promote and

  • Boehringer shuts Ben Venue unit Boehringer shuts Ben Venue unit

    Boehringer Ingelheim is to shut down its contract manufacturing unit Ben Venue Laboratories after a series of problems in recent years. ... A site-wide assessment was then carried out, with Ben Venue deciding to extended the suspension at the end of 2011.

  • NICE to update ovarian cancer drug guidelines NICE to update ovarian cancer drug guidelines

    The drug was one of a number manufactured by the troubled Ben Venue Laboratories, which faced a temporary suspension of manufacturing and distribution of drug products due to a series of

More from news
Approximately 2 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics